Markets:

Overview

News

Currencies

International

Treasuries

West Pharmaceutical Services, Inc. Common Stock (NY:WST)

340.48 -15.00 (-4.22%)

Streaming Delayed Price Updated: 10:31 AM EDT, Jul 24, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about West Pharmaceutical Services, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

18 19 Next >

West Pharma Soars After Q3 Beat, Lifts Outlook On GLP-1 Demand ↗

October 23, 2025

West Pharmaceutical posts Q3 earnings of $1.96 per share and raises 2025 guidance, driven by GLP-1 demand and strong HVP component growth.

Via Benzinga

These S&P500 stocks are gapping in today's session ↗

October 23, 2025

Wondering what's happening in today's session regarding gap up and gap down stocks? Explore the S&P500 index on Thursday to uncover the stocks that are gapping in the S&P500 index.

Via Chartmill

Las Vegas Sands Posts Upbeat Q3 Results, Joins Garrett Motion, LendingClub, Dow, Hexcel And Other Big Stocks Moving Higher On Thursday ↗

October 23, 2025

Via Benzinga

Topics Stocks

Earnings Scheduled For October 23, 2025 ↗

October 23, 2025

Via Benzinga

Wondering what's happening in today's S&P500 pre-market session? ↗

October 23, 2025

As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the S&P500 top gainers and losers shaping the early market sentiment.

Via Chartmill

West Pharmaceutical Services (NYSE:WST) Q3 2025 Earnings Top Estimates, Boosts Full-Year Outlook ↗

October 23, 2025

West Pharmaceutical Services (WST) beats Q3 2025 earnings and revenue estimates, raises full-year guidance. The strong results, led by an EPS beat, sent the stock up over 6% pre-market.

Via Chartmill

West Pharmaceutical Services’s (NYSE:WST) Q3 Sales Beat Estimates

October 23, 2025

Healthcare products company West Pharmaceutical Services (NYSE:WST) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 7.7% year on year to $804.6 million. The...

Via StockStory

Topics Earnings Economy

West Pharmaceutical Servs's Earnings Outlook ↗

October 22, 2025

Via Benzinga

West Pharmaceutical Services (WST) To Report Earnings Tomorrow: Here Is What To Expect

October 21, 2025

Healthcare products company West Pharmaceutical Services (NYSE:WST) will be reporting earnings this Thursday morning. Here’s what to look for.

Via StockStory

Topics Artificial Intelligence

3 Cash-Producing Stocks That Fall Short

October 17, 2025

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Via StockStory

Topics Economy

1 of Wall Street’s Favorite Stock on Our Buy List and 2 We Turn Down

October 16, 2025

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because...

Via StockStory

Topics Economy

3 Healthcare Stocks We Keep Off Our Radar

October 13, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have caused the...

Via StockStory

Topics Economy Stocks

WEST PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into West Pharmaceutical Services, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

October 08, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Drug Development Inputs & Services Stocks Q2 Recap: Benchmarking Medpace (NASDAQ:MEDP)

October 05, 2025

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at drug development inputs & services stocks,...

Via StockStory

Deep Dive Into West Pharmaceutical Servs Stock: Analyst Perspectives (5 Ratings) ↗

October 02, 2025

Via Benzinga

3 Reasons to Avoid WST and 1 Stock to Buy Instead

September 30, 2025

West Pharmaceutical Services has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 16.3% to $260.31 per share while the...

Via StockStory

Topics Stocks

Bill Gates Bets Big on Buffett: A Defensive Play Amidst Tech Uncertainty?

September 25, 2025

In a significant shift that has caught the attention of financial markets and online communities alike, Bill Gates, through his investment vehicle Cascade Investment, has made notable adjustments to...

Via MarketMinute

Topics Economy

Looking Into West Pharmaceutical Servs's Recent Short Interest ↗

September 25, 2025

West Pharmaceutical Servs's (NYSE: WST) short interest as a percent of float has risen 9.25% since its last report. According to exchange reported data, there are now 1.68 million shares sold short,...

Via Benzinga

West Pharmaceutical Services (WST) Stock Is Up, What You Need To Know

September 24, 2025

Shares of healthcare products company West Pharmaceutical Services (NYSE:WST) jumped 3.1% in the afternoon session after a research note from KeyBanc Capital Markets indicated positive momentum in the...

Via StockStory

Topics Artificial Intelligence Supply Chain

Top S&P500 movers in Wednesday's session ↗

September 24, 2025

Curious about the S&P500 stocks that are in motion on Wednesday? Join us as we explore the top movers within the S&P500 index during today's session.

Via Chartmill

Life Sciences Tools & Services Stocks Q2 Teardown: PacBio (NASDAQ:PACB) Vs The Rest

September 14, 2025

As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the life sciences tools & services industry, including PacBio (NASDAQ:PACB) and its...

Via StockStory

Topics Artificial Intelligence Economy

1 Cash-Heavy Stock Worth Your Attention and 2 We Question

September 04, 2025

A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face challenges like stagnating revenue, declining...

Via StockStory

Topics Economy

3 Mid-Cap Stocks That Concern Us

September 01, 2025

Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from...

Via StockStory

Topics Economy

Life Sciences Tools & Services Stocks Q2 Results: Benchmarking Illumina (NASDAQ:ILMN)

August 31, 2025

As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the life sciences tools & services industry, including Illumina (NASDAQ:ILMN) and its...

Via StockStory

Topics Artificial Intelligence Economy

1 S&P 500 Stock on Our Watchlist and 2 Facing Challenges

August 29, 2025

The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some...

Via StockStory

Topics Economy Stocks

Q2 Earnings Highs And Lows: 10x Genomics (NASDAQ:TXG) Vs The Rest Of The Life Sciences Tools & Services Stocks

August 24, 2025

Wrapping up Q2 earnings, we look at the numbers and key takeaways for the life sciences tools & services stocks, including 10x Genomics (NASDAQ:TXG) and its peers.

Via StockStory

Topics Artificial Intelligence Economy

Q2 Earnings Recap: West Pharmaceutical Services (NYSE:WST) Tops Drug Development Inputs & Services Stocks

August 24, 2025

Via StockStory

Topics Economy

What's going on in today's session: S&P500 movers ↗

August 19, 2025

Stay informed about the performance of the S&P500 index in the middle of the day on Tuesday. Uncover the top gainers and losers in today's session for valuable insights.

Via Chartmill

1 of Wall Street’s Favorite Stock on Our Watchlist and 2 We Brush Off

August 14, 2025

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional...

Via StockStory

Topics Economy Electric Vehicles

1 Healthcare Stock on Our Watchlist and 2 We Find Risky

August 07, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, and over the past six...

Via StockStory

Topics Economy Stocks

< Previous 1 2 3 4 5 6 7 8 9

...

18 19 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.